Respiratory

Help your patients have a safe and healthy academic year.

For the first time, investigators broke down into narrow age bands morbidity and mortality estimates for respiratory syncytial virus (RSV).

A recent study examined the links between breastfeeding and preterm birth history with hospitalization duration due to LRTIs in infants and toddlers.

The FDA recently announced an e-cigarette prevention campaign aimed at Native American and Alaskan Native youth using prominent social media sites and traditional media like billboards, radio, and TV.

Patience and antimicrobial stewardship are key to treating sinusitis.

A new study examines the relationship between an extended duration of mother-child breastfeeding and protective associations to asthma.

Find out the various ways you can connect and learn through the Leukemia & Lymphoma Society!

Previous investigation has shown that common measurements and tools may not be as accurate in non-White patients as they are in White patients. A new investigation dives into whether pulse oximetry falls into this category.

An investigation examines what demographic factors and less-than-optimal respiratory support in or beyond the neonatal intensive care unit can increase the risk of abnormal lunch function on extremely low gestational age newborns (ELGANs).

An investigation examines whether a treatment of hydrocortisone could lead to a reduction in moderate to severe bronchopulmonary dysplasia and neurodevelopmental outcomes at age 2 years.

What the HCP community can do to change our approach

Thirdhand smoke exposure poses a health threat to children. New research examines the factors that may lead to some children having more exposure than others.

Decreased lung function may be a result of a preterm delivery. Does treatment with long-acting β2 agonists (LABA) plus inhaled corticosteroids perform better than just inhaled corticosteroids to improve lung function in affected children?

Used to treat asthma in adolescents and adults, a clinical trial examines whether it would be effective in treating uncontrolled asthma in younger children.

In spite of the availability of effective treatments, asthma is not always well controlled among teenagers. An investigation examines whether using peers to helm education efforts can lead to improved outcomes.

The jury is out on whether testing or exposure better explains the unseasonable surge of respiratory syncytial virus.

The US Food and Drug Administration has accepted a Priority Review of the pneumococcal 15-valent conjugate vaccine VAXNEUVANCE™ in children aged 17 years and younger.

The National Institutes of Health announced the launch of a long-term study into the long ranging outcomes of recovering from COVID-19 in children, adolescents, and young adults.

An investigation examines whether safety communications from the US Food and Drug Administration (FDA) in 2017 and 2018 led to reductions in the prescription of cough and cold medications with codeine and hydrocodone.

Dr. Tan shares her must-reads from the October issue.

Between the subtle differences between viral and bacterial pneumonia and the demands or beliefs of certain parents can make an accurate diagnosis of community-acquired pneumonia (CAP) more difficult.

In cases of poorly controlled disease, even with good medication adherence, it might make sense to turn to biologics. A presentation at the virtual 2021 American Academy of Pediatrics National Conference & Exhibition covered biologics available for treating asthma and allergic skin disease.

At the virtual 2021 American Academy of Pediatrics National Conference & Exhibition, Maria Rahmandar, MD, FAAP, reviews issues surrounding teen e-cigarette use in schools, along with methods to help teens quit.

Nonadherence to medication is a frustrating element of treating patients, particularly those with chronic conditions. A session at the virtual 2021 American Academy of Pediatrics National Conference & Exhibition offers insight into the common causes behind it and how to improve adherence.

The winter season of respiratory diseases is nearly here. Knowing how to manage community-acquired pneumonia is essential.

The pandemic has increased awareness for many infectious diseases, including croup.

With COVID-19 still at large, pediatricians should prepare for a tough allergy season.

Merck has released promising topline results from their study of VAXNEUVANCE™, a 15-valent pneumococcal conjugate vaccine, in infants.

Vaping has led to some serious erosion in the campaign to end adolescent nicotine use. What drives vaping cessation in this population?

Climate change means more than stronger, more ferocious weather and hard-to-contain wildfires. Here's what it means for allergies.